STOCK TITAN

LifeStance (LFST) director-linked LLCs sell 894k shares at $10.13 average

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

LifeStance Health Group director-related entities sold a sizable block of shares. On June 26, 2026, entities associated with director Robert Bessler — Shama LLC and Vitthal LLC — executed open-market sales totaling 894,337 shares of LifeStance common stock at a weighted average price of $10.13 per share.

The filing states these sales occurred in multiple transactions within a price range of $10.00 to $10.295 per share. After these transactions, Shama LLC held 656,560 shares and Vitthal LLC held 539,763 shares of common stock. The report also shows Bessler with 57,619 shares held directly and 36,363 shares held indirectly in a separate position. Footnotes emphasize that he disclaims beneficial ownership of certain securities except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.

Insights

Director-linked LLCs sold 894k LFST shares but still retain large positions.

Entities associated with Robert Bessler, a director of LifeStance Health Group, reported open-market sales of 894,337 common shares at a weighted average price of $10.13 on June 26, 2026. The trades were executed through Shama LLC and Vitthal LLC, not as direct personal sales.

Following the transactions, Shama LLC held 656,560 shares and Vitthal LLC held 539,763 shares of common stock, while Bessler’s separate direct and other indirect positions totaled additional tens of thousands of shares. Footnotes state that he disclaims beneficial ownership except for his pecuniary interest, which is a standard legal clarification.

The filing indicates a net-sell pattern but also shows that the associated entities continue to own substantial stakes. The informational value centers on these indirect ownership changes and the remaining sizeable holdings, rather than on any change in company operations or financial performance.

Insider Bessler Robert
Role null
Sold 894,337 shs ($9.06M)
Type Security Shares Price Value
Sale Common Stock 447,168 $10.13 $4.53M
Sale Common Stock 447,169 $10.13 $4.53M
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 539,763 shares (Indirect, Vitthal LLC); Common Stock — 57,619 shares (Direct, null)
Footnotes (1)
  1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.295 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act of 1934 (the "Exchange Act") or for any other purpose. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose. Shares held of record by Alpine Glow Capital. The Reporting Person is the manager and sole member of Alpine Glow Capital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Total shares sold 894,337 shares Open-market sales on June 26, 2026 by Shama LLC and Vitthal LLC
Weighted average sale price $10.13 per share LFST common stock sales on June 26, 2026
Price range of sales $10.00–$10.295 per share Multiple transactions aggregated into weighted average price
Shama LLC shares after sale 656,560 shares LFST common stock held following June 26, 2026 transactions
Vitthal LLC shares after sale 539,763 shares LFST common stock held following June 26, 2026 transactions
Direct holdings 57,619 shares LFST common stock held directly by Robert Bessler after reported date
Other indirect holdings 36,363 shares Additional indirect LFST common stock position shown as of June 26, 2026
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action: "open-market sale" for LFST common stock transactions"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein..."
Section 16 regulatory
"for purposes of Section 16 of the Exchange Act or for any other purpose."
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bessler Robert

(Last)(First)(Middle)
C/O LIFESTANCE HEALTH GROUP, INC.
4800 N. SCOTTSDALE ROAD, SUITE 6000

(Street)
SCOTTSDALE ARIZONA 85251

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/26/2026S447,168D$10.13(1)539,763IVitthal LLC(2)
Common Stock06/26/2026S447,169D$10.13(1)656,560IShama LLC(3)
Common Stock57,619D
Common Stock36,363ISee Footnote(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.295 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act of 1934 (the "Exchange Act") or for any other purpose.
3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
4. Shares held of record by Alpine Glow Capital. The Reporting Person is the manager and sole member of Alpine Glow Capital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
By: /s/ Ryan Pardo, Attorney-in-Fact06/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did the LifeStance Health (LFST) Form 4 filed by Robert Bessler report?

The Form 4 reports that entities associated with director Robert Bessler sold 894,337 LifeStance common shares on June 26, 2026 at a weighted average price of $10.13 per share, through open-market transactions executed by Shama LLC and Vitthal LLC.

How many LFST shares were sold and at what prices on June 26, 2026?

Shama LLC and Vitthal LLC together sold 894,337 LFST shares at a weighted average price of $10.13 per share. The filing notes multiple trades within a price range from $10.00 to $10.295 per share during that trading day.

What LifeStance (LFST) share holdings remain after the reported Form 4 sales?

After the sales, Shama LLC held 656,560 LFST shares and Vitthal LLC held 539,763 shares. The filing also lists 57,619 shares held directly and 36,363 shares held indirectly in a separate position for director Robert Bessler.

Were the LFST share sales on the Form 4 made directly by Robert Bessler?

The reported LFST share sales were executed by Shama LLC and Vitthal LLC, entities associated with director Robert Bessler. Footnotes state he disclaims beneficial ownership of certain securities except to the extent of his pecuniary interest in those entities.

What does the weighted average price mean in the LFST Form 4 filing?

The weighted average price of $10.13 per LFST share means the sales occurred in many trades between $10.00 and $10.295. The average reflects the total proceeds divided by total shares sold across those individual transactions reported for June 26, 2026.

How does the LFST Form 4 describe Robert Bessler’s beneficial ownership?

Footnotes explain that Robert Bessler disclaims beneficial ownership of certain LifeStance securities, except for his pecuniary interest. The report clarifies that including these securities should not be viewed as an admission of beneficial ownership for Section 16 or other purposes.